These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37084836)

  • 1. Ameliorating the antiparasitic activity of the multifaceted drug ivermectin through a polymer nanocapsule formulation.
    de Souza ZC; Júnior FHX; Pinheiro IO; de Souza Rebouças J; de Abreu BO; Mesquita PRR; de Medeiros Rodrigues F; Quadros HC; Mendes TMF; Nguewa P; Allegretti SM; Farias LP; Formiga FR
    Int J Pharm; 2023 May; 639():122965. PubMed ID: 37084836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applications.
    Gamboa GV; Palma SD; Lifschitz A; Ballent M; Lanusse C; Passirani C; Benoit JP; Allemandi DA
    Parasitol Res; 2016 May; 115(5):1945-53. PubMed ID: 26852126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
    Dorati R; Genta I; Colzani B; Tripodo G; Conti B
    Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability Evaluation of Ivermectin-Loaded Biodegradable Microspheres.
    Dorati R; Genta I; Colzani B; Modena T; Bruni G; Tripodo G; Conti B
    AAPS PharmSciTech; 2015 Oct; 16(5):1129-39. PubMed ID: 25700978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases.
    Mohammed SW; El-Megrab NA; Hasan AA; Gomaa E
    Eur J Pharm Sci; 2024 Apr; 195():106714. PubMed ID: 38301972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivermectin-Loaded Mesoporous Silica and Polymeric Nanocapsules: Impact on Drug Loading, In Vitro Solubility Enhancement, and Release Performance.
    Velho MC; Funk NL; Deon M; Benvenutti EV; Buchner S; Hinrichs R; Pilger DA; Beck RCR
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal effects of ivermectin treatment in rats infected with Strongyloides venezuelensis.
    Mendonça JC; Gama LA; Hauschildt AT; Corá LA; Américo MF
    Acta Trop; 2019 Jun; 194():69-77. PubMed ID: 30914242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly (ε-caprolactone) nanocapsules for oral delivery of raloxifene: process optimization by hybrid design approach, in vitro and in vivo evaluation.
    Aditya N; Ravi PR; Avula US; Vats R
    J Microencapsul; 2014; 31(5):508-18. PubMed ID: 24697167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of formulation variables for the preparation of poly(epsilon-caprolactone) nanocapsules containing the local anesthetic benzocaine.
    Moraes CM; de Matos AP; Grillo R; de Melo NF; de Paula E; Dias Filho NL; Rosa AH; Fraceto LF
    J Nanosci Nanotechnol; 2011 Mar; 11(3):2450-7. PubMed ID: 21449406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained release ivermectin-loaded solid lipid dispersion for subcutaneous delivery: in vitro and in vivo evaluation.
    Lu M; Xiong D; Sun W; Yu T; Hu Z; Ding J; Cai Y; Yang S; Pan B
    Drug Deliv; 2017 Nov; 24(1):622-631. PubMed ID: 28282989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization.
    Camargo JA; Sapin A; Nouvel C; Daloz D; Leonard M; Bonneaux F; Six JL; Maincent P
    Drug Dev Ind Pharm; 2013 Jan; 39(1):146-55. PubMed ID: 22397675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endectocide activity of a new long-action formulation containing 2.25% ivermectin+1.25% abamectin in cattle.
    Borges FA; Silva HC; Buzzulini C; Soares VE; Santos E; Oliveira GP; Costa AJ
    Vet Parasitol; 2008 Aug; 155(3-4):299-307. PubMed ID: 18562119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphiphilic diblock copolymer and polycaprolactone blends to produce new vesicular nanocarriers.
    Penott-Chang E; Walther A; Millard P; Jäger A; Jäger E; Müller AH; Guterres SS; Pohlmann AR
    J Biomed Nanotechnol; 2012 Apr; 8(2):272-9. PubMed ID: 22515078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorhexidine Nanocapsule Drug Delivery Approach to the Resin-Dentin Interface.
    Priyadarshini BM; Selvan ST; Lu TB; Xie H; Neo J; Fawzy AS
    J Dent Res; 2016 Aug; 95(9):1065-72. PubMed ID: 27422859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model.
    Ali M; Afzal M; Verma M; Bhattacharya SM; Ahmad FJ; Samim M; Abidin MZ; Dinda AK
    Parasitol Res; 2014 Feb; 113(2):681-91. PubMed ID: 24366812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables.
    Camargo JA; Sapin A; Daloz D; Maincent P
    J Microencapsul; 2010; 27(7):609-17. PubMed ID: 20695833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of lyophilized oily-core poly-Ɛ-caprolactone nanocapsules to improve oral bioavailability of Olmesartan Medoxomil.
    Khattab WM; Zein El-Dein EE; El-Gizawy SA
    Drug Dev Ind Pharm; 2020 May; 46(5):795-805. PubMed ID: 32275456
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of photodynamic activity, photostability and in vitro drug release of zinc phthalocyanine-loaded nanocapsules.
    de Souza TD; Ziembowicz FI; Müller DF; Lauermann SC; Kloster CL; Santos RC; Lopes LQ; Ourique AF; Machado G; Villetti MA
    Eur J Pharm Sci; 2016 Feb; 83():88-98. PubMed ID: 26678154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization.
    Kassaee SN; Ayoko GA; Richard D; Wang T; Islam N
    Pharmaceutics; 2024 Aug; 16(8):. PubMed ID: 39204406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivermectin systemic availability in adult volunteers treated with different oral pharmaceutical formulations.
    Ceballos L; Alvarez L; Lifschitz A; Lanusse C
    Biomed Pharmacother; 2023 Apr; 160():114391. PubMed ID: 36804122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.